Determine the pharmacology of PEG-IL2 constructed to preferentially signal Treg populations via polymer technology that permits IL2 receptor binding favoring Treg expansion
|Effective start/end date||10/1/16 → 9/30/18|
- NEKTAR THERAPEUTICS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.